HOMA-IR

HOMA-IR is a measure used to assess insulin resistance, which is crucial for understanding risks related to metabolic disorders like diabetes and cardiovascular diseases.

Indexed studies indicate that HOMA-IR effectively predicts health outcomes in individuals with metabolic risk factors such as obesity or high blood pressure. It also helps identify those at higher risk of developing metabolic syndrome and retinal microvascular dysfunction. Comparisons with other indices, like the triglyceride-glucose index, show that while both are useful, HOMA-IR often provides more accurate predictions for certain conditions.

Strong connections exist between HOMA-IR and diabetes subtypes, as well as acromegaly-related changes in insulin resistance. Understanding these links can aid in early diagnosis and management of metabolic issues.

While the evidence supports its utility, further research is needed to fully establish HOMA-IR’s predictive power across diverse populations.

Sources

• Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride/glucose index. (PMID:35939943)
• HOMA-IR as a predictor of Health Outcomes in Patients with Metabolic Risk Factors: A Systematic Review and Meta-analysis. (PMID:36181637)
• Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes? (PMID:36788521)
• Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. (PMID:35090800)
• HOMA-IR value in predicting retinal microvascular dysfunction. (PMID:39816052)
• Acromegaly: Diabetes and HOMA-IR. (PMID:33357713)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._